Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.

Autor: Sanchez-Piedra C; Research Unit, Sociedad Española de Reumatologia, Madrid, Madrid, Spain., Diaz-Torne C; Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Manero J; Rheumatology, Hospital Universitario Miguel Servet, Zaragoza, Aragón, Spain., Pego-Reigosa JM; Rheumatology, Complejo Hospitalario de Vigo Hospital Xeral, Vigo, Galicia, Spain., Rúa-Figueroa Í; Rheumatology, Hospital Universitario Insulsar Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain., Gonzalez-Gay MA; Rheumatology, Hospital Universitario Marqués de Valdecilla Servicio de Medicina Interna, Santander, Cantabria, Spain., Gomez-Reino J; Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain., Alvaro-Gracia JM; Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain jalvarogracia@gmail.com.
Jazyk: angličtina
Zdroj: Annals of the rheumatic diseases [Ann Rheum Dis] 2020 Jul; Vol. 79 (7), pp. 988-990. Date of Electronic Publication: 2020 Jun 05.
DOI: 10.1136/annrheumdis-2020-217948
Abstrakt: Competing Interests: Competing interests: None declared.
Databáze: MEDLINE